These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 37941514)
41. Dopamine Inhibition Differentially Controls Excitability of Substantia Nigra Dopamine Neuron Subpopulations through T-Type Calcium Channels. Evans RC; Zhu M; Khaliq ZM J Neurosci; 2017 Mar; 37(13):3704-3720. PubMed ID: 28264982 [TBL] [Abstract][Full Text] [Related]
42. The role of alpha-synuclein in the development of the dopaminergic neurons in the substantia nigra and ventral tegmental area. Tarasova TV; Lytkina OA; Roman AY; Bachurin SO; Ustyugov AA Dokl Biol Sci; 2016; 466():5-7. PubMed ID: 27021360 [TBL] [Abstract][Full Text] [Related]
43. Nifedipine and nimodipine protect dopaminergic substantia nigra neurons against axotomy-induced cell death in rat vibrosections via modulating inflammatory responses. Daschil N; Humpel C Brain Res; 2014 Sep; 1581():1-11. PubMed ID: 25038562 [TBL] [Abstract][Full Text] [Related]
44. Morpho-Functional Changes of Nigral Dopamine Neurons in an α-Synuclein Model of Parkinson's Disease. Ledonne A; Massaro Cenere M; Paldino E; D'Angelo V; D'Addario SL; Casadei N; Nobili A; Berretta N; Fusco FR; Ventura R; Sancesario G; Guatteo E; Mercuri NB Mov Disord; 2023 Feb; 38(2):256-266. PubMed ID: 36350188 [TBL] [Abstract][Full Text] [Related]
50. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease. Ahlers-Dannen KE; Spicer MM; Fisher RA Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009 [TBL] [Abstract][Full Text] [Related]
51. Aldehyde dehydrogenase 1-positive nigrostriatal dopaminergic fibers exhibit distinct projection pattern and dopamine release dynamics at mouse dorsal striatum. Sgobio C; Wu J; Zheng W; Chen X; Pan J; Salinas AG; Davis MI; Lovinger DM; Cai H Sci Rep; 2017 Jul; 7(1):5283. PubMed ID: 28706191 [TBL] [Abstract][Full Text] [Related]
52. Dopamine and α-synuclein dysfunction in Smad3 null mice. Tapia-González S; Giráldez-Pérez RM; Cuartero MI; Casarejos MJ; Mena MÁ; Wang XF; Sánchez-Capelo A Mol Neurodegener; 2011 Oct; 6():72. PubMed ID: 21995845 [TBL] [Abstract][Full Text] [Related]
53. Striatal dopamine neurotransmission is altered in age- and region-specific manner in a Parkinson's disease transgenic mouse. Medina-Luque J; Piechocinski P; Feyen P; Sgobio C; Herms J Sci Rep; 2024 Jan; 14(1):164. PubMed ID: 38167878 [TBL] [Abstract][Full Text] [Related]
54. Inhibition of L-Type Ca Sun Y; Zhang H; Selvaraj S; Sukumaran P; Lei S; Birnbaumer L; Singh BB J Neurosci; 2017 Mar; 37(12):3364-3377. PubMed ID: 28258168 [TBL] [Abstract][Full Text] [Related]
55. A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease. Chan CS; Gertler TS; Surmeier DJ Mov Disord; 2010; 25 Suppl 1():S63-70. PubMed ID: 20187241 [TBL] [Abstract][Full Text] [Related]
56. Sox6 expression distinguishes dorsally and ventrally biased dopamine neurons in the substantia nigra with distinctive properties and embryonic origins. Pereira Luppi M; Azcorra M; Caronia-Brown G; Poulin JF; Gaertner Z; Gatica S; Moreno-Ramos OA; Nouri N; Dubois M; Ma YC; Ramakrishnan C; Fenno L; Kim YS; Deisseroth K; Cicchetti F; Dombeck DA; Awatramani R Cell Rep; 2021 Nov; 37(6):109975. PubMed ID: 34758317 [TBL] [Abstract][Full Text] [Related]
57. Exercise in an animal model of Parkinson's disease: Motor recovery but not restoration of the nigrostriatal pathway. Churchill MJ; Pflibsen L; Sconce MD; Moore C; Kim K; Meshul CK Neuroscience; 2017 Sep; 359():224-247. PubMed ID: 28754312 [TBL] [Abstract][Full Text] [Related]
58. Representation of spontaneous movement by dopaminergic neurons is cell-type selective and disrupted in parkinsonism. Dodson PD; Dreyer JK; Jennings KA; Syed EC; Wade-Martins R; Cragg SJ; Bolam JP; Magill PJ Proc Natl Acad Sci U S A; 2016 Apr; 113(15):E2180-8. PubMed ID: 27001837 [TBL] [Abstract][Full Text] [Related]
59. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease. Liu H; Jia L; Chen X; Shi L; Xie J Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294 [TBL] [Abstract][Full Text] [Related]
60. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia. Lee J; Zhu WM; Stanic D; Finkelstein DI; Horne MH; Henderson J; Lawrence AJ; O'Connor L; Tomas D; Drago J; Horne MK Brain; 2008 Jun; 131(Pt 6):1574-87. PubMed ID: 18487277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]